Dr. Christian Baum
Stuff I Worry About: High-Risk Squamous Cell Carcinoma and High-Risk Patients
December 2023
Dr. Baum presented information about tumor- and patient-specific risk factors for cutaneous squamous cell carcinoma (cSCC). First, Dr. Baum noted that the cSCC incidence in the US is increasing, with an estimated 180,000–520,000 new cases annually and a metastatic rate of 2–5%. Patients with bulky nodal disease have higher recurrence rates and lower overall survival…
In-Transit Melanoma Metastases
December 2023
Dr. Baum described melanoma in-transit metastases (ITMs) and presented an overview of current treatments. Melanoma ITMs are lesions that develop between the primary tumor site and the draining nodal basin via lymphatic seeding, separate from spreading in the blood. ITMs occur in 5–10% of patients with melanoma and typically develop within 13–18 months. Fifty percent…
Topics
- 2022 CS Plenary Sessions
- 2023 CS Plenary Sessions
- 2024 CS Plenary Sessions
- 2025 CS Plenary Sessions
- 2026 CS Plenary Sessions
- Atopic dermatitis
- Dermatology
- Editorial
- Education
- Female autoimmune disorder
- From the Foundation
- Honorary Awards
- Immunology
- Morphea
- People
- Profiles in Achievement
- Research Award Program
- Rheumatology
- Science
- Scleroderma
- Uncategorized